FibroBiologics, Inc. (Nasdaq: FBLG) announced the release and shipment of a third batch of its investigational drug product CYWC628 to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE